A randomized, multicenter, double-blind, placebo-controlled, dose-range-finding, parallel-design, phase 2 trial of oral linaclotide acetate administered to patients with irritable bowel syndrome with constipation.

Trial Profile

A randomized, multicenter, double-blind, placebo-controlled, dose-range-finding, parallel-design, phase 2 trial of oral linaclotide acetate administered to patients with irritable bowel syndrome with constipation.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Sponsors Ironwood Pharmaceuticals
  • Most Recent Events

    • 27 Oct 2010 Results were presented at the 18th United European Gastroenterology Week.
    • 20 Oct 2010 Results from a subset of patients were presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology.
    • 25 Nov 2009 Results presented at GASTRO 2009 (Joint Meeting).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top